drugset / Trial / NCT02107599

The Feasibility of Florbetapir Quantitation in Europe

NCT02107599

Phase 4 Completed 96 enrolled Avid Radiopharmaceuticals
NaSingle-groupSingle-blindDiagnostic

Summary

This study will evaluate whether the addition of quantitation as an adjunct to visual interpretations significantly improves the accuracy of Amyvid scan interpretation.

Timeline

Start
2014-03
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Background florbetapir F 18 Diagnostic / imaging agent

Indications